9 research outputs found
Numerical analysis of wave-induced current within the inhomogeneous coral reef using a refined SPH model
Experimental investigation on the infragravity wave on different reef systems under irregular wave action
SARS-CoV-2 infection impairs oculomotor functions: A longitudinal eye-tracking study
Although Severe Acute Respiratory Syndrome Coronavirus 2 infection (SARS-CoV-2) is primarily recognized as a respiratory disease, mounting evidence suggests that it may lead to neurological and cognitive impairments. The current study used three eye-tracking tasks (free-viewing, fixation, and smooth pursuit) to assess the oculomotor functions of mild infected cases over six months with symptomatic SARS-CoV-2 infected volunteers. Fifty symptomatic SARS-CoV-2 infected, and 24 self-reported healthy controls completed the eye-tracking tasks in an initial assessment. Then, 45, and 40 symptomatic SARS-CoV-2 infected completed the tasks at 2- and 6-months post-infection, respectively. In the initial assessment, symptomatic SARS-CoV-2 infected exhibited impairments in diverse eye movement metrics. Over the six months following infection, the infected reported overall improvement in health condition, except for self-perceived mental health. The eye movement patterns in the free-viewing task shifted toward a more focal processing mode and there was no significant improvement in fixation stability among the infected. A linear discriminant analysis shows that eye movement metrics could differentiate the infected from healthy controls with an accuracy of approximately 62%, even 6 months post-infection. These findings suggest that symptomatic SARS-CoV-2 infection may result in persistent impairments in oculomotor functions, and the employment of eye-tracking technology can offer valuable insights into both the immediate and long-term effects of SARS-CoV-2 infections. Future studies should employ a more balanced research design and leverage advanced machine-learning methods to comprehensively investigate the impact of SARS-CoV-2 infection on oculomotor functions
A CNN-Based Wearable System for Driver Drowsiness Detection
Drowsiness poses a serious challenge to road safety and various in-cabin sensing technologies have been experimented with to monitor driver alertness. Cameras offer a convenient means for contactless sensing, but they may violate user privacy and require complex algorithms to accommodate user (e.g., sunglasses) and environmental (e.g., lighting conditions) constraints. This paper presents a lightweight convolution neural network that measures eye closure based on eye images captured by a wearable glass prototype, which features a hot mirror-based design that allows the camera to be installed on the glass temples. The experimental results showed that the wearable glass prototype, with the neural network in its core, was highly effective in detecting eye blinks. The blink rate derived from the glass output was highly consistent with an industrial gold standard EyeLink eye-tracker. As eye blink characteristics are sensitive measures of driver drowsiness, the glass prototype and the lightweight neural network presented in this paper would provide a computationally efficient yet viable solution for real-world applications
Febuxostat Attenuates Renal Damage besides Exerting Hypouricemic Effect in Streptozotocin-Induced Diabetic Rats
Aim. In this study, we aimed to investigate the effects of febuxostat, a novel inhibitor of xanthine oxidase (XO), on renal damage in streptozotocin- (STZ-) induced diabetic rats. Methods. Diabetes was induced by the intraperitoneal injection of STZ in male Sprague-Dawley rats. Sham-injected rats served as controls. The control and diabetic rats were treated with and without febuxostat for 8 weeks, respectively. Fasting blood and 24-h urine samples were collected every 4 weeks. Rat livers were extracted for detecting gene expression, content, and bioactivity of XO. Results. Diabetic rats showed significantly increased serum uric acid (SUA), serum creatinine (SCr), and urea nitrogen (BUN) levels. Daily urinary albumin (UAE), uric acid (UUA), and creatinine (UCr) excretion were also significantly increased in these rats. In diabetic rats, at week 8, febuxostat decreased SUA by 18.9%, while UAA was increased by 52.0%. However, UCr and urinary urea nitrogen (UUN) levels remained unchanged, while SCr and BUN levels decreased by >30% in these rats. Although hepatic gene expression, content, and activity of XO increased significantly in diabetic rats, febuxostat only slightly decreased its content. Conclusions. Febuxostat significantly attenuated renal damage in STZ-induced diabetic rats in addition to exerting hypouricemic effect